Regarding “Endovascular Stent-Graft Repair of Spontaneous Isolated Dissection of the Superior Mesenteric Artery”

Jia, Zhongzhi

doi:10.1007/s00270-018-1905-4

Cited by 5 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is evidence, however, that covered stents may compromise the main branches of the SMA and also aggravate bowel ischemia. 11 In the present study, all patients received bare stents, leading to complete progressive symptom relief in all 9 patients suggesting positive outcomes. Obliteration of the dissection was evident in all the patients upon follow-up, and intestinal necrosis was not found in any of the cases.…”

Section: Discussionsupporting

confidence: 53%

“…[1][2][3][4][5][6][7] Patients with ISMAD are at a high risk of suffering both the rupture of the dissection, and symptoms of mesenteric ischemia. [1][2][3][4][5][6][7][10][11][12] Since it is a rare condition, the exact risk factors, its incidence rate and natural course of disease progression, and optimal treatment strategies are still not definitively established. The first-line treatment for ISMAD is typically a conservative approach, which has been used in the majority of previous reports where it has been reported to be successful in 12.5% to 70.6% of the cases.…”

Section: Discussionmentioning

confidence: 99%

“…There is evidence, however, that covered stents may compromise the main branches of the SMA and also aggravate bowel ischemia. 11…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection

Cao

Shi

et al. 2019

Vasc Endovascular Surg

View full text Add to dashboard Cite

Purpose: To investigate the clinical outcomes of endovascular bare stenting in patients with symptomatic isolated superior mesenteric artery (SMA) dissection (ISMAD). Methods: This study was a retrospective analysis which included a total of 9 patients with symptomatic ISMAD (7 males and 2 females, age range: 48-67 years) who were treated with endovascular bare stenting. Data regarding basic patient clinical characteristics, e-technical success of the operation, and long-term patient outcomes were assessed. Results: Endovascular bare stenting was found to be technically successful in all patients. A total of 9 stents were inserted in these 9 patients. Five patients presented with stable false lumen and 4 patients presented with shrinking of false lumen after stenting. Both the trunk and branches of the SMA remained patent in all patients after stent insertion. There was no incidence of procedure-related complications, with all patients experiencing progressive symptom relief and subsequent symptom abatement within 1 week of the operation. Over a median 24 month follow-up period (range: 12-36 months), abdominal computed tomographic angiography revealed that all patients had obliterated dissections. In addition, there were no instances of stent obstruction, intestinal necrosis, or antiplatelet related bleeding during the follow-up period. Conclusions: Endovascular bare stenting was found to be a safe and effective treatment for patients with ISMAD.

show abstract

Section: Discussionsupporting

confidence: 53%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection

Cao

Shi

et al. 2019

Vasc Endovascular Surg

View full text Add to dashboard Cite

show abstract

“…In contrast, there is evidence that covered stents may compromise the branches of the SMA and also aggravate bowel ischemia. 23 In our experience, it suggest that covered stent might be considered for type IIa or dissecting aneurysm in SMA trunk, given its generally proximal and local properties, whereas self-expanding bare stents are recommended for type IIb and type III dissections as there is no blood flow in the false lumen. When the type IIa dissection involves in multiple branches originating, the bare stents combined with the coils embolization can promote the thrombogenesis of the false lumen without affecting the collateral blood supply.…”

Section: Discussionmentioning

confidence: 91%

Mid-term outcomes of symptomatic isolated superior mesenteric artery dissection with endovascular management

Shang

et al. 2020

Vascular

View full text Add to dashboard Cite

Objectives The clinical outcomes, safety, and efficacy of endovascular management are explored for symptomatic isolated superior mesenteric artery dissection (ISMAD). Methods In this retrospective study, 51 consecutive patients with symptomatic ISMAD received endovascular management from three institutions between January 2011 and December 2019.These patients were categorized into group A (endovascular treatment was used as the first-line therapy) and group B(endovascular treatment was used as the second-line therapy). The general epidemiological data, clinical manifestations, first-episode symptoms, treatment process, imaging findings, follow-up outcomes were analyzed from the medical records. Results A total of 51 patients with endovascular management were collected in this study. Significant differences were observed between the two groups with respect to the course (150 h vs. 57 h; p < 0.001), intestinal ischemia (26.32% vs. 6,25%; p = 0.04) and dissection length (45.26 ± 13.78 mm vs. 63.37 ± 12.73 mm; p < 0.001). Technical success rate was 90.2% (46/51). There was significant difference in the MOD (42.27 ± 23.41 min vs. 76.63 ± 28.62 min p < 0.001), MPSRT (4.67 ± 2.65 h vs. 7.32 ± 2.49 h, p = 0.02), LOS (9.52 ± 3.72 days vs. 11.86 ± 4.13 days; p = 0.01) between the two groups. The bleeding complication rate was 7.84% (one patient in group A and three patients in group B). A total of 48 (94.12%, 48/51) patients were followed up for a median of 36.51 months (range, 4–87 months). Positive events of the SMA were achieved in 81.25% (39/48), and negative events of the SMA were achieved in 18.75% (8/48) based on the follow-up contrast-enhanced CT scan. Conclusions Endovascular management of symptomatic ISMAD has a high technical success rate and efficient at controlling symptoms. Furthermore, as more positive events occur, endovascular management should be encouraged early when pain persists after conservative management or there are signs of disease progression.

show abstract

“…Recently, self-expanding bare stents that have better compliance and more smooth deliver system, with the advantage of tolerating the curvature that is usually located in the proximal opening of SMA are the most widely used in mesenteric artery diseases [6] to maintain the original arterial radian, prevent new damage on intima, and also ensure the patency of branches. Despite the relatively poor radical strength, it is considered to be enough to render support.…”

Section: Discussionmentioning

confidence: 99%

Clinical analysis and literature review of a complicated superior mesenteric artery stenosis with intestinal necrosis: A case report

Zhou¹,

Huang²,

Chen³

et al. 2023

Medicine

View full text Add to dashboard Cite

Rationale: Superior mesenteric artery (SMA) stenosis, as a common arterial disease, if coexists with other possible causes of abdominal pain, is complicated, which may require not only conservative treatment but also surgical intervention. Patient concerns: A 64-year-old male patient who was admitted to our hospital with pain located around the umbilicus and right lower quadrant for 12 hours. Diagnosis: SMA stenosis was initially diagnosed. After balloon dilatation of SMA and stent implantation, computed tomography angiography reexamination showed that the stent was migrated and the stenosis reoccurred. During the ileocecal resection and enterolysis, the necrotic bowel was found and cut open, and the intestinal fistula was found. Combined with his abdominal surgery history, the patient was diagnosed with complicated SMA stenosis with intestinal necrosis. Interventions: The balloon dilatation of SMA and stent implantation was performed. Because the stent was migrated and the stenosis reoccurred, so a balloon stent was implanted in the proximal stenosis of SMA again. The patient’s symptoms were relieved and reoccurred again. The ileocecal resection and enterolysis were performed. Outcomes: The computed tomography angiography showed that the stents were well deployed and unobstructed after 9 months follow-up. Lessons: When dealing with undetermined abdominal pain that especially has something to do with mesenteric artery ischemia, if there coexists with other possible causes of abdominal pain, we cannot only focus on vascular diseases. We should be vigilant, integrate multiple factors and their interactions to guarantee the accuracy and timeliness of diagnosis and therapy.

show abstract

Regarding “Endovascular Stent-Graft Repair of Spontaneous Isolated Dissection of the Superior Mesenteric Artery”

Cited by 5 publications

References 6 publications

Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection

Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection

Mid-term outcomes of symptomatic isolated superior mesenteric artery dissection with endovascular management

Clinical analysis and literature review of a complicated superior mesenteric artery stenosis with intestinal necrosis: A case report

Contact Info

Product

Resources

About